Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-12-27

Clinical Trial Update: Sclerotherapy and Candida Antigen in Treatment of Common Warts [NA]

View source ↗

Summary

Clinical trial update on using sclerotherapy and Candida antigen to treat common warts, with the study currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Candida antigen (candida antigen)

Snippet

Sponsor: Sohag University | Conditions: Common Wart | NA | Status: NOT_YET_RECRUITING